Universal Health (UHS) Tops Q4 EPS by 22c, Revenues Beat; Offers FY20 EPS/Revenue Guidance

Universal Health (NYSE: UHS) reported Q4 EPS of $2.79, $0.22 better than the analyst estimate of $2.57. Revenue for the quarter came in at $2.9 billion versus the consensus estimate of $2.87 billion.

GUIDANCE:

Universal Health sees FY2020 EPS of $10.30-$11.00, versus the consensus of $10.75. Universal Health sees FY2020 revenue of $11.96-12.116 billion, versus the consensus of $11.86 billion.

For earnings history and earnings-related data on Universal Health (UHS) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Pfizer lung cancer drug misses survival goal in Phase 3 trial
• Robinhood prices $2B convertible notes offering due 2029